K.J. Harrison & Partners Inc Lowers Stock Position in Danaher Corporation $DHR

K.J. Harrison & Partners Inc trimmed its stake in Danaher Corporation (NYSE:DHR) by 62.0% during the third quarter, Holdings Channel.com reports. The fund owned 2,000 shares of the conglomerate’s stock after selling 3,265 shares during the period. K.J. Harrison & Partners Inc’s holdings in Danaher were worth $421,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. WFA of San Diego LLC purchased a new stake in Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the second quarter valued at $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher in the third quarter valued at $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the 3rd quarter valued at $28,000. Finally, Tripletail Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth about $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.1%

Shares of NYSE:DHR opened at $209.35 on Friday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The firm’s 50 day moving average price is $225.62 and its 200 day moving average price is $216.09. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market cap of $148.04 billion, a price-to-earnings ratio of 41.54, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the prior year, the firm posted $2.14 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is currently 25.40%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have weighed in on DHR shares. Jefferies Financial Group lifted their target price on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Argus set a $265.00 price objective on shares of Danaher in a research note on Wednesday, January 14th. Wells Fargo & Company upped their target price on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. JPMorgan Chase & Co. increased their target price on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, January 29th. Finally, Evercore reissued an “outperform” rating and issued a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average target price of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.